Assignee
ANSORGE SIEGFRIED
DE·2 granted patents·6 pending applications·17 citations·filing 2001–2011
Top patents by PatentIndex Score
8 records- 0173US8263636B2Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological inflammatory, neuronal and other diseasesANSORGE SIEGFRIED·Filed 2004·Granted Sep 11, 2012·17 cites·14 claims
- 0238US2007037785A1Novel dipeptidyl peptidase IV inhibitors used for functionally influencing different cells and treating immunological, infammatory, neuronal, and other diseasesANSORGE SIEGFRIED·Filed 2004·Application pending·0 cites
- 0338US2007037752A1Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseasesANSORGE SIEGFRIED·Filed 2004·Application pending·0 cites
- 0437US2007042938A1Use of dpiv and apn inhibitors for the treatment of dermatalogical diseases involving the hyperproliferation and modified differentiation conditions of fibroblastsANSORGE SIEGFRIED·Filed 2004·Application pending·0 cites
- 0534US2004147434A1Use of enzyme inhibitors of the dipeptidypeptidase iv (ec3.3.14.5) in addition to the aminopeptidase n (ec 3.4.11.2), individually or in a combination thereof, and pharmaceutical preparations thereof for the prevention and/or therapy of ischaemia-caused acute and chronic neurodegenerative process and illnesses, for exampleANSORGE SIEGFRIED·Filed 2001·Application pending·0 cites
- 0630US8470855B2Dual-use peptidase inhibitors as prodrugs for a therapy of inflammatory and other diseasesANSORGE SIEGFRIED·Filed 2006·Granted Jun 25, 2013·0 cites·29 claims
- 0728US2012028995A1Novel compounds for medical use as peptidase effectorsANSORGE SIEGFRIED·Filed 2011·Application pending·0 cites
- 0827US2012258960A1Novel multifunctional peptidase inhibitors, especially for medical useANSORGE SIEGFRIED·Filed 2010·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →